36281795|t|FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates beta-amyloid aggregation.
36281795|a|Alzheimer's disease (AD) is one of the most prominent neurodegenerative diseases. Results from animal and cellular models suggest that FAD-deficient forms of NAD(P)H quinone oxidoreductase 1 (NQO1) may accelerate the aggregation of Alzheimer's amyloid-beta peptide (Abeta1-42). Here, we examined in vitro whether NQO1 and its FAD-deficient P187S mutation (NQO1*2) directly interact with Abeta1-42 and modify its rate of aggregation. When monitored using the fluorescence of either noncovalent thioflavin T (ThT) or HiLyte Fluor 647 (HF647) dye covalently attached to the Abeta1-42 peptide, the aggregation kinetics of Abeta1-42 were markedly more rapid in the presence of NQO1*2 than the wild-type (WT) NQO1. Experiments using apo-NQO1 indicate that this increase is linked to the inability of NQO1*2 to bind to FAD. Furthermore, dicoumarol, an NQO1 inhibitor that binds near the FAD-binding site and stabilizes NQO1*2, markedly decreased the aggregation kinetics of Abeta1-42. Imaging flow cytometry confirmed in-vitro coaggregation of NQO1 isoforms and Abeta1-42. Abeta1-42 alone forms rod-shaped fibril structures while in the presence of NQO1 isoforms, Abeta1-42 is incorporated in the middle of larger globular protein aggregates surrounded by NQO1 molecules. Isothermal titration calorimetry (ITC) analysis indicates that Abeta1-42 interacts with NQO1 isoforms with a specific stoichiometry through a hydrophobic interaction with positive enthalpy and entropy changes. These data define the kinetics, mechanism, and shape of coaggregates of Abeta1-42 and NQO1 isoforms and the potential relevance of FAD-deficient forms of NQO1 for amyloid aggregation diseases.
36281795	0	3	FAD	Gene	5663
36281795	14	19	P187S	ProteinMutation	tmVar:p|SUB|P|187|S;HGVS:p.P187S;VariantGroup:0;CorrespondingGene:1728;RS#:1800566;CorrespondingSpecies:9606;CA#:126904
36281795	32	64	NAD(P)H:quinone oxidoreductase 1	Gene	1728
36281795	66	70	NQO1	Gene	1728
36281795	96	120	beta-amyloid aggregation	Disease	MESH:C000718787
36281795	122	141	Alzheimer's disease	Disease	MESH:D000544
36281795	143	145	AD	Disease	MESH:D000544
36281795	176	202	neurodegenerative diseases	Disease	MESH:D019636
36281795	257	260	FAD	Gene	5663
36281795	280	312	NAD(P)H quinone oxidoreductase 1	Gene	1728
36281795	314	318	NQO1	Gene	1728
36281795	354	386	Alzheimer's amyloid-beta peptide	Disease	MESH:D000544
36281795	435	439	NQO1	Gene	1728
36281795	448	451	FAD	Gene	5663
36281795	462	467	P187S	ProteinMutation	tmVar:p|SUB|P|187|S;HGVS:p.P187S;VariantGroup:0;CorrespondingGene:1728;RS#:1800566;CorrespondingSpecies:9606;CA#:126904
36281795	478	482	NQO1	Gene	1728
36281795	615	627	thioflavin T	Chemical	MESH:C009462
36281795	629	632	ThT	Chemical	MESH:C009462
36281795	637	653	HiLyte Fluor 647	Chemical	-
36281795	655	660	HF647	Chemical	-
36281795	794	798	NQO1	Gene	1728
36281795	825	829	NQO1	Gene	1728
36281795	916	920	NQO1	Gene	1728
36281795	934	937	FAD	Gene	5663
36281795	952	962	dicoumarol	Chemical	MESH:D001728
36281795	967	971	NQO1	Gene	1728
36281795	1002	1005	FAD	Gene	5663
36281795	1034	1038	NQO1	Gene	1728
36281795	1159	1163	NQO1	Gene	1728
36281795	1264	1268	NQO1	Gene	1728
36281795	1371	1375	NQO1	Gene	1728
36281795	1475	1479	NQO1	Gene	1728
36281795	1683	1687	NQO1	Gene	1728
36281795	1728	1731	FAD	Gene	5663
36281795	1751	1755	NQO1	Gene	1728
36281795	1760	1788	amyloid aggregation diseases	Disease	MESH:C000718787
36281795	Association	MESH:D001728	5663
36281795	Association	MESH:C000718787	5663
36281795	Association	MESH:C000718787	RS#:1800566;HGVS:p.P187S;CorrespondingGene:1728
36281795	Bind	1728	5663
36281795	Negative_Correlation	MESH:D001728	1728
36281795	Association	MESH:D000544	1728
36281795	Association	MESH:C000718787	1728
36281795	Association	MESH:C000718787	1728

